What Doctors Don't Tell YouThe pharmaceutical industry argues that it would cost too much to be more open about the potential dangers of its products. ... ...
If you get the Daily Mail, you've probably read the story they broke about Professor Jean Golding, of the Institute of Child Health in Bristol, who recently performed a study showing a link betw ...
The news that Boots has decided to withdraw the heart drug Manoplax because it was killing patients received massive media coverage just recently. ...
The UK drug regulatory bodies (Medicines Control Agency and the committee on the Safety of medicines), in a rare request for self justification, have been asked to defend their recommendations on ...
The Food and Drug Administration, the American drug regulator, is set to tighten controls on the safety of drugs so that adverse reactions can be identified more quickly. ...
Amid the sudden British ban on Halcion (triazolam) by the Committee on the Safety of Medicines, Upjohn has admitted that data on some adverse effects were missing from the summary originally submi ...
Smokers who rely on nicotine patches or chewing gum to help them kick the habit may continue to run an increased risk of heart disease. ...
Most new drugs are simply old drugs with a bit of window dressing to justify double the price tag. Yet, the dangers multiply from these novel twists and aren’t picked up until after the drugs are taken by millions.
Often, the short-term clinical trials, which also often involve only small numbers of ‘healthy’ patients don’t uncover the worst side-effects, which then only emerge when a drug is taken by the public at large.
New drugs seem to be getting more toxic. Since 1997, more drugs have been withdrawn because of toxicity than in any other era in the history of modern medicine.
